The New York Times rolled out their latest attack on President Donald Trump on Monday, blistering him with a fake news assault that told readers of his incompetence. The story: Trump, in his shortsightedness, refused to buy more than 100 million doses of the Pfizer COVID vaccine when the doses were up for grabs months ago. Since Pfizer’s vaccine works as a double dose, that will only be enough to inoculate 50 million Americans, leaving the rest of us poor saps to get infected and (probably) die. Trump’s terribleness strikes again.
So, what’s the truth?
Well, it does appear to be true that the Trump administration only purchased 100 million doses of the vaccine from Pfizer, but that is about the extent of the reality to be found in the Times story. In an interview with NBC Nightly News, HHS Secretary Alex Azar said that the administration had purchased 600 million doses of vaccine from other qualified manufacturers and that any word to the contrary was pointless fearmongering.
“I know in the Pfizer deal the government agreed to pay for 100 million doses and perhaps 500 million beyond that. To your knowledge has the government taken the option to buy more of what now appears to be a very successful vaccine?” NBC anchor Lester Holt asked.
“So, Lester, you’re correct. Across the six different vaccine manufacturers that we placed contracts with, with each of them we guaranteed the purchase of 100 million doses of vaccine so that we would have 600 million doses of vaccine across a broad portfolio,” Azar replied. “With Pfizer we have an option to buy an additional 500 million more. I’m not able to reveal discussions around potential procurements because that’s what we call procurement sensitive information. But we are continuing to work across manufacturers to expand the availability of releasable FDA approved vaccine as quickly as possible.”
Having failed to push Azar into a corner, Holt insisted that a new push by the administration to prioritize the vaccination of Americans was a sign that Trump officials are expecting to see shortages.
Azar replied: “No. We are prioritizing the manufacturer of vaccine here in America and the procurement of that vaccine for the benefit of Americans.”
As you would EXPECT an American administration to do.
Speaking of which, is there any doubt that if the Trump administration had purchased a whole lot more of the vaccine that liberal critics would be knocking the U.S. for “selfishly” cutting other countries out of the mix? In fact, we’re pretty sure we’ve already seen articles to that effect, so they’re actually trying to have it both ways. Trump didn’t buy enough vaccine…and he also bought TOO MUCH vaccine.
If only there was a vaccine for Trump Derangement Syndrome in the works…